3-(Methylamino)-1-Phenyl-1-Ppropanol

3-(Methylamino)-1-Phenyl-1-Ppropanol - Names and Identifiers

Name	3-Hydroxy-N-methyl-3-phenyl-propylamine
Synonyms	3-METHYLAMINO-1-PHENYLPROPANOL 3-methylamino-1-phenyl-1-propanol 3-METHYLAMINO-1-PHENYL-1-PROPANOL 3-(METHYLAMINO)-1-PHENYLPROPAN-1-OL 3-(methylamino)-1-phenylpropan-1-ol 3-(Methylamino)-1-Phenyl-1-Ppropanol 3-Hydroxy-N-methyl-3-phenylpropylamine 3-HYDROXY-N-METHYL-3-PHENYLPROPYLAMINE N-Methyl-3-phenyl-3-hydroxypropylamine N-METHYL-3-PHENYL-3-HYDROXYPROPYLAMINE 3-Hydroxy-N-methyl-3-phenyl-propylamine N-METHYL-3-HYDROXY-3-PHENYL PROPYLAMINE N-Methyl-3-hydroxy-3-phenyl-propylamine N-methyl 3-phenyl-3-hydroxy-1-propanamine ALPHA-[2-(METHYLAMINO)ETHYL]BENZYL ALCOHOL alpha-[2-(methylamino)ethyl]benzyl alcohol ALPHA-(2-METHYLAMINO)-ETHYLBENZENEMETHANOL (3R)-3-hydroxy-N-methyl-3-phenylpropan-1-aminium
CAS	42142-52-9
EINECS	255-679-8
InChI	InChI=1/C10H15NO/c1-11-8-7-10(12)9-5-3-2-4-6-9/h2-6,10-12H,7-8H2,1H3/p+1/t10-/m1/s1
InChIKey	XXSDCGNHLFVSET-UHFFFAOYSA-N

3-(Methylamino)-1-Phenyl-1-Ppropanol - Physico-chemical Properties

Molecular Formula	C10H15NO
Molar Mass	165.24
Density	1.017±0.06 g/cm3(Predicted)
Melting Point	64 °C
Boling Point	170 °C / 31mmHg
Flash Point	114.8°C
Solubility	DMSO (Soluble), Methanol (Slightly)
Vapor Presure	0.037Pa at 25℃
Appearance	Solid
Color	Off-White to Pale Yellow
pKa	14.24±0.20(Predicted)
Storage Condition	Keep in dark place,Inert atmosphere,Room temperature
MDL	MFCD00674078
Physical and Chemical Properties	Appearance: white to yellow crystals Melting Point: 59 - 65 ℃

3-(Methylamino)-1-Phenyl-1-Ppropanol - Risk and Safety

Hazard Symbols	Xn - Harmful
Risk Codes	22 - Harmful if swallowed
Safety Description	36/37 - Wear suitable protective clothing and gloves.
WGK Germany	3
HS Code	2922199695

3-(Methylamino)-1-Phenyl-1-Ppropanol - Reference Information

LogP

0.98

introduction

methamphetamine is a pharmaceutical intermediate that can be used to prepare tomoxetine. Tomoxetine, developed by Eli Lilly, is a selective norepinephrine reuptake inhibitor. It is the only non-central nervous stimulant approved by the US FDA for the treatment of attention deficit hyperactivity disorder (ADHD). It is a first-line drug recommended by the American Children and Adolescents Psychiatric Association (AACAP) for the treatment of attention deficit hyperactivity disorder.

Last Update：2024-04-09 02:00:08